人血管生成素-1|Human ANG-1
產(chǎn)品名稱(chēng): 人血管生成素-1|Human ANG-1
產(chǎn)品型號(hào): C02-130-06-20ug
產(chǎn)品展商: peprotech
產(chǎn)品文檔: 無(wú)相關(guān)文檔
簡(jiǎn)單介紹
人血管生成素-1|Human ANG-1系列產(chǎn)品主要適用于試驗(yàn)室或生化科研相關(guān)試驗(yàn),CANSPEC品質(zhì)提供人血管生成素-1|Human ANG-1性能**,中文名稱(chēng)為人血管生成素-1|Human ANG-1。產(chǎn)品人血管生成素-1|Human ANG-1以其優(yōu)良的品質(zhì)滿足您不同科研實(shí)驗(yàn)的多種需求。
人血管生成素-1|Human ANG-1
的詳細(xì)介紹
產(chǎn)品名稱(chēng):人血管生成素-1|Human ANG-1
產(chǎn)品規(guī)格:
C02-130-06-20ug | 人血管生成素-1|Human ANG-1 | 20ug | ¥1,960 |
C02-130-06-5ug | 人血管生成素-1|Human ANG-1 | 5ug | ¥680 |
單 位:瓶
關(guān) 鍵 字:人血管生成素-1|Human ANG-1
CANSPEC品質(zhì)提供的人血管生成素-1|Human ANG-1性能**,英文名稱(chēng)人血管生成素-1|Human ANG-1,簡(jiǎn)稱(chēng)為人血管生成素-1|Human ANG-1,中文名稱(chēng)為人血管生成素-1|Human ANG-1 。
產(chǎn)品人血管生成素-1|Human ANG-1以其優(yōu)良的品質(zhì)滿足您不同實(shí)驗(yàn)的多種需求。并保證每批人血管生成素-1|Human ANG-1的質(zhì)量和人血管生成素-1|Human ANG-1 品質(zhì)優(yōu)良。
Synonyms : | Angiopoietin-1 |
Description : | Angiopoietin-1 (Ang-1) is a secreted ligand for Tie-2, a tyrosine-kinase receptor expressed primarily on vascular endothelial cells and early hematopoietic cells. Ang-1/ Tie-2 signaling promotes angiogenesis during the development, remodeling, and repair of the vascular system. Transgenic mice lacking expression of either Ang-1 or Tie-2 fail to develop a fully functional cardiovascular system and die before birth. Postnatally, the angiogenic activity of Ang-1/Tie-2 is required during normal tissue repair and remodeling of the female endometrium in the menstrual cycle. Ang-1/Tie-2 signaling appears to be regulated by Angiopoietin-2 (Ang-2), a natural antagonist for Tie-2 that exerts its effects through an internal autocrine loop mechanism. In addition to suppressing endothelial cell activation by inhibiting the expression of adhesion and inflammatory molecules, Ang-1 enhances endothelial cell survival and capillary morphogenesis, and lessens capillary permeability. As such, Ang-1 has a potential to become an effective therapeutic agent for treating various endothelium disorders, including several severe human pulmonary diseases. The efficacy of cell-based Ang-1 gene therapy for acute lung injury (ALI) has recently been studied in a rat model of ALI (1). The results of this study show that such therapy can markedly improve lung condition and suggest that Ang-1 therapy may represent a potential new strategy for the treatment and/or prevention of acute respiratory distress injury (ARDI), a significant cause of morbidity and mortality in critically ill patients. Recombinant human ANG-1, derived from HeLa cells, is a C-terminal histidine tagged glycoprotein which migrates with an apparent molecular mass of 60.0 – 70.0 kDa by SDS-PAGE under reducing conditions. Sequencing analysis shows N-terminal sequences starting with Ser-20 and with Asp-70 of the 498 amino acid precursor protein. |
Catalog #: | 130-06 |
Source : | HeLa cells |
Stability : | The lyophilized protein is stable for at least 2 years from date of receipt at -200C. Reconstituted ANG-1 is stable for at least 3 months when stored in working aliquots with a carrier protein at -200C. Avoid repeated freeze/thaw cycles. |
Purity : | Greater than 95% by SDS-PAGE gel and HPLC analyses. |
Endotoxin Level : | Endotoxin level is less than 0.1 ng per μg (1EU/μg). |
Biological Activity : | Determined by the dose-dependent stimulation of the proliferation of human umbilical vein endothelial cells (HUVEC). |
Selected References : | Selected List of References Citing This PeproTech Product |
PubMed Link : | Angiopoietin-1 |
Country of Origin : | USA |
|